16.09.2015 Views

Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and ... - clinicalevidence

A Textbook of Clinical Pharmacology and ... - clinicalevidence

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CHAPTER 20<br />

MOOD DISORDERS<br />

● Depressive illnesses <strong>and</strong> antidepressants 116<br />

● Lithium, tryptophan <strong>and</strong> St John’s wort 121<br />

● Special groups 122<br />

DEPRESSIVE ILLNESSES AND<br />

ANTIDEPRESSANTS<br />

Many forms of depression are recognized clinically <strong>and</strong> most<br />

respond well to drugs. From a biochemical viewpoint, there<br />

are probably different types of depression (which do not correspond<br />

predictably to clinical variants) depending on which<br />

neurotransmitter is involved, <strong>and</strong> these may respond differently<br />

to different drugs.<br />

PATHOPHYSIOLOGY: INSIGHTS FROM<br />

ANTIDEPRESSANT DRUG ACTIONS<br />

The monoamine theory of mood is mainly based on evidence<br />

from the actions of drugs.<br />

1. Reserpine, which depletes neuronal stores of noradrenaline<br />

(NA) <strong>and</strong> 5-hydroxytryptamine (5HT) <strong>and</strong> α-methyltyrosine,<br />

which inhibits NA synthesis, cause depression.<br />

2. Tricyclic antidepressants (TCA) of the amitriptyline type<br />

(which raise the synaptic concentration of NA <strong>and</strong> 5HT)<br />

are antidepressant.<br />

3. Monoamine oxidase inhibitors (MAOIs, which increase<br />

total brain NA <strong>and</strong> 5HT) are antidepressant.<br />

On the basis of these actions, it was suggested that depression<br />

could be due to a cerebral deficiency of monoamines. One difficulty<br />

with this theory is that amfetamine <strong>and</strong> cocaine, which<br />

act like tricyclic drugs in raising the synaptic NA content, are<br />

not antidepressive, although they do alter mood. Even worse,<br />

the tricyclic antidepressants block amine reuptake from synapses<br />

within one or two hours of administration, but take from ten<br />

days to four weeks to alleviate depression. Such a long timecourse<br />

suggests a resetting of postsynaptic or presynaptic<br />

receptor sensitivity.<br />

Another theory of depression is the serotonin-only hypothesis.<br />

This theory emphasizes the role of 5HT <strong>and</strong> downplays that of<br />

NA in the causation of depression, <strong>and</strong> is backed by the effectiveness<br />

of the selective serotonin reuptake inhibitors, or SSRI<br />

class of drugs, in the treatment of depression. However, it also<br />

does not explain the delay in onset of the clinical effect of<br />

antidepressant drugs, including the SSRIs, <strong>and</strong> again receptor<br />

resetting has to be invoked. Also, many str<strong>and</strong>s of evidence suggest<br />

that NA does indeed have an important role in depression.<br />

The permissive hypothesis of mania/depression suggests<br />

that the control of emotional behaviour results from a balance<br />

between NA <strong>and</strong> 5HT. According to this theory, both the<br />

manic phase <strong>and</strong> the depressive phase of bipolar disorder are<br />

characterized by low central 5HT function. Evidence suggests<br />

that brain 5HT systems dampen or inhibit a range of functions<br />

involving other neurotransmitters. Mood disorders result from<br />

the removal of the serotonin damper. This hypothesis postulates<br />

that low levels of 5HT permit abnormal levels of NA to<br />

cause depression or mania. If 5HT cannot control NA <strong>and</strong> NA<br />

falls to abnormally low levels, the patient becomes depressed.<br />

On the other h<strong>and</strong>, if the level of 5HT falls <strong>and</strong> the level of<br />

NA becomes abnormally high, the patient becomes manic.<br />

According to this hypothesis, antidepressant drugs are effective<br />

to the degree that they restore the ability of 5HT to control<br />

NA, thus restoring the critical balance that controls emotional<br />

behaviour. A recently available class of antidepressant drugs,<br />

serotonin-noradrenaline reuptake inhibitors (SNRI), work by<br />

selectively blocking reuptake of both NA <strong>and</strong> 5HT, thereby<br />

increasing levels of both monoamines. The SNRIs have very<br />

little affinity for other postsynaptic receptor sites <strong>and</strong> are therefore<br />

less likely to produce some of the side effects associated<br />

with TCA.<br />

Dysregulation of the hypothalamic–pituitary–adrenal axis<br />

is a common biological marker of depression <strong>and</strong> the value of<br />

antiglucocorticoid drugs is under investigation.<br />

GENERAL PRINCIPLES OF MANAGEMENT<br />

Depression is common, but under-diagnosed. It can be recognized<br />

during routine consultations, but additional time may<br />

be needed. Genetic <strong>and</strong> social factors are often relevant. Drug<br />

treatment is not usually appropriate at the mild end of the<br />

severity range. Drugs are used in more severe depression,<br />

especially if it has melancholic (‘endogenous’) features. Even<br />

if depression is attributable to external factors (‘exogenous’),

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!